Advancing Clinical Trial Equity

Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials. In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias. Look for more on the Summit findings coming soon to the ACCC website. Guest: Colleen Lewis, MSN, ANP-BC, AOCNP Director of Clinical Operations, Phase I Program; Interim Director, Infusion Center Clifton The Winship Cancer Institute of Emory University Related Content: ACCC Community Oncology Research Institute ASCO-ACCC Initiative to Increase Racial and Ethnic Diversity in Clinical Trials Real World Lessons from COVID-19 [Video Podcast] Ep 52: End of Life Disparities [Podcast] Ep 51: Cultural Humility and Sensitivity [Podcast] Ep 49: Building Trust with Marginalized Groups [Mini-Podcast] In Pursuit of Equity: Diversity in Clinical Research Participation [Webinar] Practical Solutions to Better Engage Cancer Professionals with Communities of Color [Webinar] Implementation of a Health Disparities & Equity Program at the Duke Cancer Institute, Paving the Way for APPs in Clinical Research [Abstract 95] Role of Oncology Advanced Practitioners to Enhance Clinical Research Research Review: Making Clinical Trials More Inclusive, Diverse, Accessible, and Representative Phase 1 Clinical Trials in the Elderly: Enrollment Challenges Bias and stereotyping among research and clinical professionals: perspectives on minority recruitment for oncology clinical trials